Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
Over the last 12 months, insiders at Balchem Corporation have bought $0 and sold $20.77M worth of Balchem Corporation stock.
On average, over the past 5 years, insiders at Balchem Corporation have bought $0 and sold $5.11M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 3,000 shares for transaction amount of $254,220 was made by MASON SCOTT C (Vice President) on 2019‑08‑05.
2024-07-31 | Sale | SVP and GM, Specialty Products | 7,750 0.0242% | $180.05 | $1.4M | -1.28% | ||
2024-07-30 | Sale | VP & Chief Accounting Officer | 4,804 0.0149% | $178.93 | $859,560 | 0.00% | ||
2024-05-10 | Sale | SVP & Chief Technology Officer | 1,929 0.0059% | $154.45 | $297,935 | +9.16% | ||
2024-05-08 | Sale | director | 5,000 0.0154% | $152.98 | $764,902 | +11.15% | ||
2024-03-08 | Sale | SVP & Chief HR Officer | 5,339 0.0166% | $157.52 | $840,985 | +5.48% | ||
2024-03-04 | Sale | director | 1,333 0.0041% | $156.89 | $209,128 | +4.35% | ||
2024-02-26 | Sale | VP & Chief Accounting Officer | 7,000 0.0217% | $155.19 | $1.09M | +4.77% | ||
2024-02-23 | Sale | VP & Chief Accounting Officer | 9,180 0.0284% | $156.37 | $1.44M | +3.74% | ||
2024-02-22 | Sale | Chairman, President & CEO | 34,350 0.1059% | $154.29 | $5.3M | +4.74% | ||
2024-02-21 | Sale | Chairman, President & CEO | 29,679 0.0924% | $153.58 | $4.56M | +5.05% | ||
2024-02-21 | Sale | VP & Chief Accounting Officer | 15,000 0.047% | $154.74 | $2.32M | +5.05% | ||
2024-02-21 | Sale | SVP & Chief Technology Officer | 11,100 0.0345% | $153.21 | $1.7M | +5.05% | ||
2023-09-11 | Sale | director | 3,800 0.0117% | $131.57 | $499,979 | +10.58% | ||
2023-05-02 | Sale | SVP & Chief Technology Officer | 2,300 0.0071% | $130.36 | $299,837 | +3.29% | ||
2022-08-12 | Sale | Vice President | 1,000 0.0031% | $131.12 | $131,121 | -2.34% | ||
2022-08-05 | Sale | Vice President | 2,629 0.0082% | $127.01 | $333,904 | +2.35% | ||
2022-08-03 | Sale | Vice President | 1,401 0.0043% | $125.02 | $175,148 | +3.58% | ||
2021-08-09 | Sale | Chief Accounting Officer | 10,520 0.0329% | $132.02 | $1.39M | +5.87% | ||
2021-08-06 | Sale | Chief Accounting Officer | 12,248 0.0381% | $134.04 | $1.64M | +3.74% | ||
2020-11-13 | Sale | Vice President | 3,000 0.009% | $103.00 | $309,000 | +23.20% |
Harris Theodore L | Chairman, President & CEO | 66412 0.2043% | $160.74 | 0 | 2 | |
Fischer David B | director | 9009 0.0277% | $160.74 | 0 | 2 | |
van Gunsteren Job Leonard | SVP and GM, Specialty Products | 8540 0.0263% | $160.74 | 0 | 4 | |
Tignor Michael Brent | SVP & Chief HR Officer | 8368 0.0257% | $160.74 | 0 | 1 | |
Wineinger Matthew David | director | 6162 0.019% | $160.74 | 0 | 1 | |
Sestrick Michael Robert | SVP & Chief Technology Officer | 4878 0.015% | $160.74 | 0 | 3 | |
Backus William A. | VP & Chief Accounting Officer | 132 0.0004% | $160.74 | 0 | 13 | |
FITZPATRICK FRANK | Vice President Administration | 73191 0.2251% | $160.74 | 1 | 37 | <0.0001% |
PUTNAM DANA E. | V P & General Manger | 44716 0.1376% | $160.74 | 0 | 2 | |
MITCHELL KENNETH P | director | 31018 0.0954% | $160.74 | 0 | 8 | |
WEDRAL ELAINE R | director | 29697 0.0914% | $160.74 | 1 | 11 | <0.0001% |
TELEVANTOS JOHN Y | director | 28326 0.0871% | $160.74 | 1 | 7 | <0.0001% |
Richardson Paul H | VP, R&D | 28188 0.0867% | $160.74 | 0 | 13 | |
MCMILLAN EDWARD | director | 25739 0.0792% | $160.74 | 0 | 12 | |
ROSSI DINO A | 25068 0.0771% | $160.74 | 0 | 107 | ||
Houston Matthew David | General Counsel/Secretary | 20050 0.0617% | $160.74 | 0 | 9 | |
LUDWIG DAVID F | Vice President, Specialty & In | 18976 0.0584% | $160.74 | 0 | 47 | |
MCDERMOTT FRANCIS X | director | 17256 0.0531% | $160.74 | 0 | 4 | |
Premdas Perry W | director | 13950 0.0429% | $160.74 | 1 | 0 | +2.8% |
COOMBS PAUL D | director | 11494 0.0354% | $160.74 | 2 | 0 | +37.54% |
MASON SCOTT C | Vice President | 9675 0.0298% | $160.74 | 1 | 1 | +19.3% |
Knutson Daniel E | director | 1495 0.0046% | $160.74 | 1 | 0 | +7.43% |
AMMIDON HOYT JR | director | 0 0% | $160.74 | 0 | 3 | |
MINIGER ROBERT T | VP Human Resources | 0 0% | $160.74 | 0 | 18 |
BlackRock | $766.44M | 15.26 | 4.95M | -0.86% | -$6.66M | 0.02 | |
The Vanguard Group | $609.87M | 12.14 | 3.94M | +3.81% | +$22.38M | 0.01 | |
APG Asset Management | $435.78M | 9.37 | 3.04M | +4.74% | +$19.71M | 0.76 | |
Wasatch Advisors | $291.59M | 5.8 | 1.88M | -1.5% | -$4.43M | 1.53 | |
State Street | $190.46M | 3.79 | 1.23M | +1.37% | +$2.57M | 0.01 | |
Conestoga Capital Advisors, LLC | $174.38M | 3.47 | 1.13M | +3.89% | +$6.53M | 2.56 | |
Geode Capital Management | $131.14M | 2.61 | 846,205 | +13.07% | +$15.16M | 0.01 | |
Geneva Capital Management LLC | $118.3M | 2.36 | 763,471 | -0.49% | -$579,513.26 | 2.09 | |
Dimensional Fund Advisors | $107.15M | 2.13 | 691,484 | +0.58% | +$619,644.78 | 0.03 | |
Morgan Stanley | $82.97M | 1.65 | 535,452 | -8.48% | -$7.69M | 0.01 | |
ClearBridge Investments | $78.43M | 1.56 | 506,143 | -2.96% | -$2.39M | 0.06 | |
JPMorgan Chase | $74.43M | 1.48 | 480,356 | +18.69% | +$11.72M | 0.01 | |
Ameriprise Financial | $68.78M | 1.37 | 443,894 | -1.43% | -$1M | 0.02 | |
Schroder Investment Management Group | $64.02M | 1.27 | 413,147 | -3.44% | -$2.28M | 0.08 | |
Northern Trust | $60.55M | 1.21 | 390,782 | -2.26% | -$1.4M | 0.01 | |
Charles Schwab | $52.92M | 1.05 | 341,529 | +3.15% | +$1.62M | 0.01 | |
Stephens Investment Management Group LLC | $50.62M | 1.01 | 326,708 | -0.56% | -$287,432.25 | 0.68 | |
GW&K Investment Management | $46.3M | 0.92 | 298,789 | -2.13% | -$1.01M | 0.41 | |
BNY Mellon | $42.49M | 0.85 | 274,196 | -5.27% | -$2.36M | 0.01 | |
Congress Asset Management Co Ma | $40M | 0.8 | 258,116 | +7.7% | +$2.86M | 0.29 | |
Ci Private Wealth Llc | $39.61M | 0.79 | 255,614 | -2.69% | -$1.09M | 0.02 | |
William Blair Investment Management | $33.43M | 0.67 | 215,727 | +0.59% | +$197,251.35 | 0.09 | |
Royal Bank of Canada | $33.03M | 0.66 | 213,200 | -12.99% | -$4.93M | 0.01 | |
Santa Monica Partners Lp | $30.77M | 0.61 | 198,604 | -2.17% | -$681,786.87 | 21.28 | |
T. Rowe Price | $29.93M | 0.6 | 193,146 | +32.19% | +$7.29M | <0.01 | |
Renaissance Technologies | $26.57M | 0.53 | 171,500 | -5.82% | -$1.64M | 0.04 | |
Grantham Mayo Van Otterloo & Co LLC | $25.73M | 0.51 | 166,075 | +78.41% | +$11.31M | 0.08 | |
Montanaro Asset Management | $23.4M | 0.47 | 151,000 | 0% | +$0 | 4.22 | |
Bank of Montreal | $22.06M | 0.43 | 140,325 | +0.85% | +$185,991.26 | 0.01 | |
Tributary Capital Management | $20.89M | 0.42 | 134,821 | -1.43% | -$304,011.90 | 1.71 | |
Nuveen | $20.51M | 0.41 | 132,336 | +0.74% | +$150,146.56 | 0.01 | |
Assenagon Asset Management S.A. | $19.77M | 0.39 | 127,594 | New | +$19.77M | 0.05 | |
SEI Investments Company | $19.81M | 0.39 | 127,822 | +4.07% | +$774,867.00 | 0.03 | |
Envestnet Asset Management Inc | $16.11M | 0.32 | 103,968 | +11.12% | +$1.61M | 0.01 | |
CalPERS | $15.93M | 0.32 | 102,817 | -0.64% | -$101,957.10 | 0.01 | |
Comerica | $15.28M | 0.3 | 98,620 | +3.59% | +$529,310.34 | 0.07 | |
RhumbLine Advisers | $14.44M | 0.29 | 93,164 | -0.23% | -$33,314.19 | 0.01 | |
Legal & General | $14.31M | 0.29 | 92,331 | +0.33% | +$47,569.65 | <0.01 | |
Salem Investment Counselors | $13.15M | 0.26 | 84,845 | 0% | +$0 | 0.44 | |
Invesco | $13.06M | 0.26 | 84,276 | -4.55% | -$623,053.94 | <0.01 | |
Allspring Global Investments | $12.9M | 0.26 | 83,221 | +1.9% | +$240,637.35 | 0.02 | |
Scout Investments | $10.43M | 0.21 | 68,590 | -5.93% | -$658,223.19 | 0.26 | |
Public Sector Pension Investment Board | $10.24M | 0.2 | 66,092 | -1.23% | -$127,058.99 | 0.08 | |
VanEck | $9.97M | 0.2 | 64,344 | -2.36% | -$240,634.87 | 0.02 | |
Swiss National Bank | $9.85M | 0.2 | 63,600 | 0% | +$0 | 0.01 | |
Goldman Sachs | $9.65M | 0.19 | 62,249 | -7.69% | -$803,571.40 | <0.01 | |
Credit Suisse | $9.28M | 0.19 | 59,872 | +6.08% | +$531,478.48 | 0.01 | |
ROYCE & ASSOCIATES INC | $9.05M | 0.18 | 58,436 | 0% | +$0 | 0.08 | |
ProShares | $8.34M | 0.17 | 53,837 | -18.71% | -$1.92M | 0.02 | |
DekaBank | $8.18M | 0.16 | 53,300 | +3.9% | +$306,754.22 | 0.02 |